Skip to main content
Top
Published in: Cancer Causes & Control 10/2015

01-10-2015 | Review article

Impact of pre-diagnosis behavior on risk of death from esophageal cancer: a systematic review and meta-analysis

Authors: Paul P. Fahey, Kylie-Ann Mallitt, Thomas Astell-Burt, Glenn Stone, David C. Whiteman

Published in: Cancer Causes & Control | Issue 10/2015

Login to get access

Abstract

Purpose

Most people diagnosed with esophageal cancer will die from their disease, but it is not known whether survival is influenced by pre-morbid behavior. We undertook a systematic review and meta-analysis to investigate the impact of pre-diagnosis behavior on risk of death for esophageal cancer.

Methods

We performed a systematic review of studies reporting on the relationship between pre-diagnosis smoking, alcohol consumption, overweight and obesity, physical activity and regular consumption of nonsteroidal anti-inflammatory drugs, and risk of death from esophageal squamous cell carcinoma (ESCC) and adenocarcinomas (EACs). Study characteristics are presented and aggregate results are compiled using meta-analysis.

Results

From an initial pool of 644 non-duplicate records, 13 articles arising from 12 studies met the inclusion criteria. Considerable variation was observed between studies in location, measurement categories, adjustment for other risks, and results. Pooled estimates suggested that for ESCC pre-diagnosis smoking was associated with a 1.19 times [95 % confidence interval (CI) 1.04–1.36] increased risk of death and pre-diagnosis alcohol consumption with a 1.36 times increased risk of death (95 % CI 1.15–1.61). No significant effects were observed for EAC. We observed a lower risk of death for both ESCC and EAC associated with high pre-diagnosis body mass index (BMI) ≥25 kg/m2 (ESCC hazard ratio 0.80, 95 % CI 0.67–0.95; EAC 0.80, 95 % CI 0.68–0.95), although there was significant heterogeneity across studies.

Conclusions

Our findings suggest that a number of modifiable pre-diagnosis risk factors have a carryover effect on the risk of death from esophageal cancer. These include smoking, drinking alcohol, and BMI.
Appendix
Available only for authorised users
Literature
1.
go back to reference World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. AICR, Washington World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. AICR, Washington
2.
go back to reference Hongo M, Nagasaki Y, Shoji T (2009) Epidemiology of esophageal cancer: orient to occident. Effects of chronology, geography and ethnicity. J Gastroenterol Hepatol 24(5):729–735CrossRefPubMed Hongo M, Nagasaki Y, Shoji T (2009) Epidemiology of esophageal cancer: orient to occident. Effects of chronology, geography and ethnicity. J Gastroenterol Hepatol 24(5):729–735CrossRefPubMed
3.
go back to reference American Cancer Society (2011) Global cancer facts & figures, 2nd edn. American Cancer Society, Atlanta American Cancer Society (2011) Global cancer facts & figures, 2nd edn. American Cancer Society, Atlanta
4.
go back to reference Corley DA, Kerlikowske K, Verma R, Buffler P (2003) Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology 124(1):47–56CrossRefPubMed Corley DA, Kerlikowske K, Verma R, Buffler P (2003) Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology 124(1):47–56CrossRefPubMed
5.
go back to reference Friedenreich CM, Neilson HK, Lynch BM (2010) State of the epidemiological evidence on physical activity and cancer prevention. Eur J Cancer 46(14):2593–2604CrossRefPubMed Friedenreich CM, Neilson HK, Lynch BM (2010) State of the epidemiological evidence on physical activity and cancer prevention. Eur J Cancer 46(14):2593–2604CrossRefPubMed
6.
go back to reference Demark-Wahnefried W, Aziz NM, Rowland JH, Pinto BM (2005) Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol 23(24):5814–5830CrossRefPubMedCentralPubMed Demark-Wahnefried W, Aziz NM, Rowland JH, Pinto BM (2005) Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol 23(24):5814–5830CrossRefPubMedCentralPubMed
7.
go back to reference National Center for Health Statistics (2014) Health, United States, 2013: with special feature on prescription drugs. National Center for Health Statistics, Hyattsville National Center for Health Statistics (2014) Health, United States, 2013: with special feature on prescription drugs. National Center for Health Statistics, Hyattsville
8.
go back to reference Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 283(15):2008–2012CrossRefPubMed Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 283(15):2008–2012CrossRefPubMed
9.
go back to reference Jüni P, Witschi A, Bloch R, Egger M (1999) The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 282(11):1054–1060CrossRefPubMed Jüni P, Witschi A, Bloch R, Egger M (1999) The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 282(11):1054–1060CrossRefPubMed
10.
go back to reference Borenstein M, Hedges LV, Higgins JP, Rothstein HR (2009) Introduction to meta-analysis. Wiley, ChichesterCrossRef Borenstein M, Hedges LV, Higgins JP, Rothstein HR (2009) Introduction to meta-analysis. Wiley, ChichesterCrossRef
12.
go back to reference Park SM, Lim MK, Shin SA, Yun YH (2006) Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study. J Clin Oncol 24(31):5017–5024. doi:10.1200/jco.2006.07.0243 CrossRefPubMed Park SM, Lim MK, Shin SA, Yun YH (2006) Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study. J Clin Oncol 24(31):5017–5024. doi:10.​1200/​jco.​2006.​07.​0243 CrossRefPubMed
13.
go back to reference Sundelöf M, Lagergren J, Ye W (2008) Patient demographics and lifestyle factors influencing long-term survival of oesophageal cancer and gastric cardia cancer in a nationwide study in Sweden. Eur J Cancer 44(11):1566–1571CrossRefPubMed Sundelöf M, Lagergren J, Ye W (2008) Patient demographics and lifestyle factors influencing long-term survival of oesophageal cancer and gastric cardia cancer in a nationwide study in Sweden. Eur J Cancer 44(11):1566–1571CrossRefPubMed
14.
go back to reference Thrift A, Nagle C, Fahey P, Smithers B, Watson D, Whiteman D (2012) Predictors of survival among patients diagnosed with adenocarcinoma of the esophagus and gastroesophageal junction. Cancer Causes Control 23(4):555–564. doi:10.1007/s10552-012-9913-1 CrossRefPubMed Thrift A, Nagle C, Fahey P, Smithers B, Watson D, Whiteman D (2012) Predictors of survival among patients diagnosed with adenocarcinoma of the esophagus and gastroesophageal junction. Cancer Causes Control 23(4):555–564. doi:10.​1007/​s10552-012-9913-1 CrossRefPubMed
15.
go back to reference Thrift AP, Nagle CM, Fahey PP, Russell A, Smithers BM, Watson DI, Whiteman DC, for the Australian Cancer Study Clinical Follow-Up S (2012) The influence of prediagnostic demographic and lifestyle factors on esophageal squamous cell carcinoma survival. Int J Cancer. doi:10.1002/ijc.27420 PubMedCentral Thrift AP, Nagle CM, Fahey PP, Russell A, Smithers BM, Watson DI, Whiteman DC, for the Australian Cancer Study Clinical Follow-Up S (2012) The influence of prediagnostic demographic and lifestyle factors on esophageal squamous cell carcinoma survival. Int J Cancer. doi:10.​1002/​ijc.​27420 PubMedCentral
16.
go back to reference Trivers KF, de Roos AJ, Gammon MD, Vaughan TL, Risch HA, Olshan AF, Schoenberg JB, Mayne ST, Dubrow R, Stanford JL, Abrahamson P, Rotterdam H, West AB, Fraumeni JF Jr, Chow W-H (2005) Demographic and lifestyle predictors of survival in patients with esophageal or gastric cancers. Clin Gastroenterol Hepatol 3(3):225–230CrossRefPubMed Trivers KF, de Roos AJ, Gammon MD, Vaughan TL, Risch HA, Olshan AF, Schoenberg JB, Mayne ST, Dubrow R, Stanford JL, Abrahamson P, Rotterdam H, West AB, Fraumeni JF Jr, Chow W-H (2005) Demographic and lifestyle predictors of survival in patients with esophageal or gastric cancers. Clin Gastroenterol Hepatol 3(3):225–230CrossRefPubMed
17.
go back to reference Aghcheli K, Marjani HA, Nasrollahzadeh D, Islami F, Shakeri R, Sotoudeh M, Abedi-Ardekani B, Ghavamnasiri MR, Razaei E, Khalilipour E (2011) Prognostic factors for esophageal squamous cell carcinoma—a population-based study in Golestan Province, Iran, a high incidence area. PLoS One 6(7):e22152CrossRefPubMedCentralPubMed Aghcheli K, Marjani HA, Nasrollahzadeh D, Islami F, Shakeri R, Sotoudeh M, Abedi-Ardekani B, Ghavamnasiri MR, Razaei E, Khalilipour E (2011) Prognostic factors for esophageal squamous cell carcinoma—a population-based study in Golestan Province, Iran, a high incidence area. PLoS One 6(7):e22152CrossRefPubMedCentralPubMed
18.
go back to reference Jing C, Huang Z, Duan Y, Xiao X, Zhang R, Jiang J (2012) Folate intake, methylenetetrahydrofolate reductase polymorphisms in association with the prognosis of esophageal squamous cell carcinoma. Asian Pac J Cancer Prev 13:647–651CrossRefPubMed Jing C, Huang Z, Duan Y, Xiao X, Zhang R, Jiang J (2012) Folate intake, methylenetetrahydrofolate reductase polymorphisms in association with the prognosis of esophageal squamous cell carcinoma. Asian Pac J Cancer Prev 13:647–651CrossRefPubMed
19.
go back to reference Sehgal S, Kaul S, Gupta B, Dhar M (2012) Risk factors and survival analysis of the esophageal cancer in the population of Jammu, India. Indian J Cancer 49(2):245CrossRefPubMed Sehgal S, Kaul S, Gupta B, Dhar M (2012) Risk factors and survival analysis of the esophageal cancer in the population of Jammu, India. Indian J Cancer 49(2):245CrossRefPubMed
20.
go back to reference Shitara K, Matsuo K, Hatooka S, Ura T, Takahari D, Yokota T, Abe T, Kawai H, Tajika M, Kodaira T (2010) Heavy smoking history interacts with chemoradiotherapy for esophageal cancer prognosis: a retrospective study. Cancer Sci 101(4):1001–1006CrossRefPubMed Shitara K, Matsuo K, Hatooka S, Ura T, Takahari D, Yokota T, Abe T, Kawai H, Tajika M, Kodaira T (2010) Heavy smoking history interacts with chemoradiotherapy for esophageal cancer prognosis: a retrospective study. Cancer Sci 101(4):1001–1006CrossRefPubMed
21.
go back to reference Wu X, Chen VW, Andrews PA, Ruiz B, Correa P (2007) Incidence of esophageal and gastric cancers among Hispanics, non-Hispanic Whites and non-Hispanic Blacks in the United States: subsite and histology differences. Cancer Causes Control 18(6):585–593CrossRefPubMed Wu X, Chen VW, Andrews PA, Ruiz B, Correa P (2007) Incidence of esophageal and gastric cancers among Hispanics, non-Hispanic Whites and non-Hispanic Blacks in the United States: subsite and histology differences. Cancer Causes Control 18(6):585–593CrossRefPubMed
22.
go back to reference Cescon DW, Bradbury PA, Asomaning K, Hopkins J, Zhai R, Zhou W, Wang Z, Kulke M, Su L, Ma C (2009) p53 Arg72Pro and MDM2 T309G polymorphisms, histology, and esophageal cancer prognosis. Clin Cancer Res 15(9):3103–3109CrossRefPubMedCentralPubMed Cescon DW, Bradbury PA, Asomaning K, Hopkins J, Zhai R, Zhou W, Wang Z, Kulke M, Su L, Ma C (2009) p53 Arg72Pro and MDM2 T309G polymorphisms, histology, and esophageal cancer prognosis. Clin Cancer Res 15(9):3103–3109CrossRefPubMedCentralPubMed
23.
go back to reference Samadi F, Babaei M, Yazdanbod A, Fallah M, Nouraie M, Nasrollahzadeh D, Sadjadi A, Derakhshan MH, Shokuhi B, Fuladi R (2007) Survival rate of gastric and esophageal cancers in Ardabil province, North-West of Iran. Arch Iran Med 10(1):32–37PubMed Samadi F, Babaei M, Yazdanbod A, Fallah M, Nouraie M, Nasrollahzadeh D, Sadjadi A, Derakhshan MH, Shokuhi B, Fuladi R (2007) Survival rate of gastric and esophageal cancers in Ardabil province, North-West of Iran. Arch Iran Med 10(1):32–37PubMed
24.
go back to reference Salek R, Bezenjani SE, Saedi HS, Ashkiki MHH, Hosainzade SM, Mohtashami S, Aghai MA, Bahar MM, Ghavamnasiri MR (2009) A geographic area with better outcome of esophageal carcinoma: is there an effect of ethnicity and etiologic factors? Oncology 77(3–4):172–177CrossRefPubMed Salek R, Bezenjani SE, Saedi HS, Ashkiki MHH, Hosainzade SM, Mohtashami S, Aghai MA, Bahar MM, Ghavamnasiri MR (2009) A geographic area with better outcome of esophageal carcinoma: is there an effect of ethnicity and etiologic factors? Oncology 77(3–4):172–177CrossRefPubMed
25.
go back to reference Hubbard VS (2000) Defining overweight and obesity: what are the issues? Am J Clin Nutr 72(5):1067–1068PubMed Hubbard VS (2000) Defining overweight and obesity: what are the issues? Am J Clin Nutr 72(5):1067–1068PubMed
26.
go back to reference Ferronha I, Bastos A, Lunet N (2012) Prediagnosis lifestyle exposures and survival of patients with gastric cancer: systematic review and meta-analysis. Eur J Cancer Prev 21(5):449–452CrossRefPubMed Ferronha I, Bastos A, Lunet N (2012) Prediagnosis lifestyle exposures and survival of patients with gastric cancer: systematic review and meta-analysis. Eur J Cancer Prev 21(5):449–452CrossRefPubMed
27.
28.
go back to reference Hong L, Zhang H, Zhao Q, Han Y, Yang J, Brain L (2013) Relation of excess body weight and survival in patients with esophageal adenocarcinoma: a meta-analysis. Dis Esophagus 26(6):623–627CrossRefPubMed Hong L, Zhang H, Zhao Q, Han Y, Yang J, Brain L (2013) Relation of excess body weight and survival in patients with esophageal adenocarcinoma: a meta-analysis. Dis Esophagus 26(6):623–627CrossRefPubMed
29.
go back to reference Parkin E, O’Reilly DA, Sherlock DJ, Manoharan P, Renehan AG (2014) Excess adiposity and survival in patients with colorectal cancer: a systematic review. Obes Rev 15(5):434–451CrossRefPubMed Parkin E, O’Reilly DA, Sherlock DJ, Manoharan P, Renehan AG (2014) Excess adiposity and survival in patients with colorectal cancer: a systematic review. Obes Rev 15(5):434–451CrossRefPubMed
30.
go back to reference Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2013) GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. International Agency for Research on Cancer. http://globocan.iarc.fr. Accessed 04 Sept 2014 Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2013) GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. International Agency for Research on Cancer. http://​globocan.​iarc.​fr. Accessed 04 Sept 2014
Metadata
Title
Impact of pre-diagnosis behavior on risk of death from esophageal cancer: a systematic review and meta-analysis
Authors
Paul P. Fahey
Kylie-Ann Mallitt
Thomas Astell-Burt
Glenn Stone
David C. Whiteman
Publication date
01-10-2015
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 10/2015
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-015-0635-z

Other articles of this Issue 10/2015

Cancer Causes & Control 10/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine